Large study aims to advance personalized breast cancer drugs

03/17/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The University of Minnesota and the Mayo Clinic are taking part in a study to identify which drug candidates for breast cancer would best benefit different groups of patients. The research, conducted at 17 centers nationwide, might reduce by 10 years the time it takes to get a new drug approved, said Dr. Tufia Haddad, head of the research at the university.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR